About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Antonio | 153 Studies

Clinical Trials Prostate CancerSan Antonio

Prostate Cancer Clinical Trials in San Antonio

Find 153 clinical trials for prostate cancer near San Antonio, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 153 trials

CompletedDiet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceRATIONALE: Eating a diet high in vegetables may slow down disease progression in patients with prostate cancer.NCT01238172·Fairbanks, Alaska and 179 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialThis phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer…NCT04513717·Fairbanks, Alaska and 601 others

CompletedImpact of Exercise on Prognostic Biomarkers Related to Prostate CancerThe goal of this study is to demonstrate the impact of a home based exercise program versus wait-list control to modulate circulating prognostic biomarkers in men with prostate…NCT03397030·San Antonio, Texas and 1 other

Completed64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)The aim of this study is to determine the safety and efficacy of 64Cu-SAR-BBN and determine the ability of 64Cu-SAR-BBN Positron emission tomography (PET)/computed tomography (CT)…NCT05407311·Los Angeles, California and 7 others

TerminatedExtension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsParticipants responding well in Study FE200486 CS06 (NCT00117949) were given the opportunity to continue treatment with degarelix under a clinical study until FE200486 was…NCT00117312·Anaheim, California and 11 others

TerminatedRegistry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging EvaluationsThe purpose of this observational research registry is to understand the real-world use of Illuccix PET/CT in prostate cancer, and how results from this testing impact patient's…NCT06655064·Fresno, California and 8 others

TerminatedA Degarelix Trial in Patients With Prostate CancerA phase III extension trial comparing the efficacy and safety of degarelix 3 month depot with the established therapy Zoladex 3 month implant in patients with prostate cancer.NCT01242748·Aurora, Colorado and 62 others

Active not recruitingTalazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCThis study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with…NCT03395197·Anchorage, Alaska and 369 others

CompletedA Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate CancerGX301 is an experimental therapeutic vaccine directed against human telomerase, an enzyme playing an essential role in cancer cell proliferation.NCT02293707·Alessandria and 23 others

CompletedEfficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerSome patients with prostate cancer benefit from androgen deprivation therapy which reduces levels of testosterone.NCT01415960·San Diego, California and 24 others

TerminatedTo Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate CancerTo determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.NCT04843319·Tucson, Arizona and 10 others

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others

RecruitingStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerThis phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants…NCT03678025·Gilbert, Arizona and 337 others

CompletedTrial of eRapa in Prostate Cancer PatientsThis study is to determine the safety, pharmacokinetics/pharmacodynamics, and immunologic impact of encapsulated rapamycin in patients with low risk prostate cancer under active…NCT03618355·San Antonio, Texas

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

CompletedImaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.A prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA) 7.3…NCT04186819·Birmingham, Alabama and 33 others

Active not recruitingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialThis phase III trial uses the Decipher risk score to guide therapy selection.NCT05050084·Birmingham, Alabama and 575 others

TerminatedHC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)This study is a multinational Phase 3, randomized, double-blind, non-inferiority, efficacy and safety study of oral HC-1119 (80 mg/day) versus enzalutamide (160 mg/day) in…NCT03850795·Denver, Colorado and 57 others

TerminatedStudy of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate CancerStage 2B: NanoTherm ablation of focal prostate cancer in small lesions in Gleason 3+4 disease.NCT05010759·Tampa, Florida and 3 others

Active not recruitingPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized…NCT01436968·Gilbert, Arizona and 72 others

PreviousPage 7 of 8Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma